|
Diabetes Care, Vol 17, Issue 12 1397-1403, Copyright © 1994 by American Diabetes Association
Hypoglycemia unawareness in IDDM
M Mokan, A Mitrakou, T Veneman, C Ryan, M Korytkowski, P Cryer and J Gerich
Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania.
OBJECTIVE--To assess the characteristics of patients with hypoglycemia
unawareness (development of neuroglycopenia without appropriate prior
autonomic warning symptoms) and its predisposing factors. RESEARCH DESIGN
AND METHODS--We studied 43 insulin-dependent diabetes mellitus patients who
were objectively categorized as having or not having hypoglycemia using the
stepped hypoglycemic clamp technique in which plasma glucose was clamped at
plateaus of 4.3, 3.6, 3.0, and 2.3 mmol/l and a statistical criterion
(onset of autonomic warning symptoms at a plasma glucose concentration 2 SD
below normal) and examined their clinical characteristics and hormonal,
symptomatic, and cognitive responses. RESULTS--Eleven (26%) of the patients
were classified as having hypoglycemia unawareness. Compared with the other
patients, unaware patients had a lower HbA1c level (P < 0.01), a longer
duration of diabetes (P < 0.01), and a history of more severe
hypoglycemia (P < 0.003). During experimental hypoglycemia,
counterregulatory hormone responses, neuroglycopenic symptoms, and
cognitive dysfunction all began at lower plasma glucose concentrations in
unaware patients (P < 0.01, 0.03, and 0.01, respectively). Moreover,
although the magnitudes of their plasma catecholamine responses and
autonomic symptoms were reduced (both, P < 0.01), the plasma
catecholamine levels at which autonomic symptoms began was not altered.
Finally, as seen from glucose infusion rates necessary to maintain
identical plasma glucose levels, patients with hypoglycemia unawareness had
increased sensitivity to insulin (P < 0.001). CONCLUSIONS--Our results
confirm an association between hypoglycemia unawareness and duration of
diabetes, glycemic control, and occurrence of severe hypoglycemia, and in
addition provide evidence that both autonomic and neuroglycopenic symptoms
are affected and that insulin sensitivity is increased, but beta-adrenergic
sensitivity is not diminished.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Fan, Y. Ding, H. Cheng, D. X. Gram, R. S. Sherwin, and R. J. McCrimmon
Amplified Hormonal Counterregulatory Responses to Hypoglycemia in Rats After Systemic Delivery of a SUR-1-Selective K+ Channel Opener?
Diabetes,
December 1, 2008;
57(12):
3327 - 3334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. N. Zammitt, R. E. Warren, I. J. Deary, and B. M. Frier
Delayed Recovery of Cognitive Function Following Hypoglycemia in Adults With Type 1 Diabetes: Effect of Impaired Awareness of Hypoglycemia
Diabetes,
March 1, 2008;
57(3):
732 - 736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Cheng, L. Zhou, W. Zhu, A. Wang, C. Tang, O. Chan, R. S. Sherwin, and R. J. McCrimmon
Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E705 - E712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. de Galan, S. J. Rietjens, C. J. Tack, S. P. van der Werf, C. G. J. Sweep, J. W. M. Lenders, and P. Smits
Antecedent Adrenaline Attenuates the Responsiveness to But Not the Release of Counterregulatory Hormones during Subsequent Hypoglycemia
J. Clin. Endocrinol. Metab.,
November 1, 2003;
88(11):
5462 - 5467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. V. Jorgensen, U. Pedersen-Bjergaard, A. K. Rasmussen, and K. Borch-Johnsen
The Impact of Severe Hypoglycemia and Impaired Awareness of Hypoglycemia on Relatives of Patients With Type 1 Diabetes
Diabetes Care,
April 1, 2003;
26(4):
1106 - 1109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Korytkowski, A. Thomas, L. Reid, M. B. Tedesco, W. E. Gooding, and J. Gerich
Glimepiride Improves Both First and Second Phases of Insulin Secretion in Type 2 Diabetes
Diabetes Care,
September 1, 2002;
25(9):
1607 - 1611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Ryan, D. Dulay, C. Suprasongsin, and D. J. Becker
Detection of Symptoms by Adolescents and Young Adults With Type 1 Diabetes During Experimental Induction of Mild Hypoglycemia: Role of hormonal and psychological variables
Diabetes Care,
May 1, 2002;
25(5):
852 - 858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Fruehwald-Schultes, W. Kern, K. M. Oltmanns, S. Sopke, B. Toschek, J. Born, H. L. Fehm, and A. Peters
Metformin Does Not Adversely Affect Hormonal and Symptomatic Responses to Recurrent Hypoglycemia
J. Clin. Endocrinol. Metab.,
September 1, 2001;
86(9):
4187 - 4192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fritsche, M. Stumvoll, H. U. Häring, and J. E. Gerich
Reversal of Hypoglycemia Unawareness in a Long-Term Type 1 Diabetic Patient by Improvement of {beta}-Adrenergic Sensitivity after Prevention of Hypoglycemia
J. Clin. Endocrinol. Metab.,
February 1, 2000;
85(2):
523 - 525.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. R. Burge, K. Schmitz-Fiorentino, C. Fischette, C. R. Qualls, and D. S. Schade
A Prospective Trial of Risk Factors for Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Mellitus
JAMA,
January 14, 1998;
279(2):
137 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. Veneman and D. W. Erkelens
Hypoglycemia Unawareness in Noninsulin-Dependent Diabetes Mellitus
J. Clin. Endocrinol. Metab.,
June 1, 1997;
82(6):
1682 - 1684.
[Full Text]
[PDF]
|
 |
|
Copyright © 1994 by the American Diabetes Association.
|
|
| |
|